Pay as you go. Fixed prices. No subscriptions
Check Eligibility
From
£85/month
  • GLP-1 Specialist Clinicians · UK Registered
    Reviewed within 1 working day

Clinician-led weight management for  Prediabetes & Insulin Resistance.

Prediabetes is your body’s warning signal – and the window to act is now. Our GLP-1 specialist clinicians provide a medication for insulin resistance and weight loss programme that addresses your condition directly. No GP referral needed. 

Check My Eligibility

Takes 5 minutes
· No commitment · Reviewed within 1 working day

  • No GP referral needed
  • GLP-1 specialist clinicians
  • 3-weekly check-ins
  • Fully online
  • Results may vary
photo 1571019613454 1cb2f99b2d8b
Programme members
70%
progression risk without action
Ellipse 276 3
Ellipse 275 (3)
Ellipse 274 (4)
Prediabetes & Insulin Resistance.
Ellipse 276 3
7M

People in the UK estimated to have prediabetes

Up to 70% of people with prediabetes will develop Type 2 diabetes without intervention. GLP-1 medicated weight management is among the most effective prevention tools available.

Source: Diabetes UK, 2024 · View source ↗

The Challenge

Prediabetes rarely feels urgent — but the window to reverse it is closing

Prediabetes has no symptoms — until it becomes Type 2

Most people with prediabetes feel completely normal. No pain, no obvious warning. By the time Type 2 diabetes develops, long-term complications are already beginning. The time to act is now — before the diagnosis.
📖 NHS England — Prediabetes Overview, 2024

Insulin resistance makes weight loss biologically harder

When your cells resist insulin, your body produces more of it. High insulin promotes fat storage — particularly visceral fat — and makes weight loss harder. This is not a willpower issue. GLP-1 medication directly targets insulin resistance.
📖 Tabák AG et al., Prediabetes: a high-risk state, The Lancet, 2012

Long waits can delay progress

When weight is affecting your health, waiting months for support can feel frustrating. WeightFall gives you faster access to clinician-led weight management, starting with a review within 1 working day
📖 NHS England Referral to Treatment Data, Q3 2024
58%
Ellipse 655

reduction in Type 2 diabetes risk achievable with 5–7% weight loss

📖 Finnish Diabetes Prevention Study, NEJM, 2001

70%
Ellipse 655

of people with prediabetes will develop Type 2 diabetes without intervention

📖 Diabetes UK — Prediabetes Statistics, 2024
14mo
Ellipse 655

Average NHS wait for diabetes prevention support — England 2024

📖 NHS England, Referral to Treatment Statistics, 2024

Ellipse 655 (1)
Ellipse 656 (1)

No need for subscriptions,

get weight management programme through us for the lowest price
The Programme Approach

A clinician-managed
programme built around your condition

WeightFall combines GLP-1 medication with specialist clinical oversight a managed programme, not just a prescription service.
Clinician-prescribed · Condition-aware

Medicated Weight Management

GLP-1 medication assessed and prescribed by your GLP-1 specialist clinician, with dose titration specifically calibrated to your diabetes medication history, blood sugar control, and health profile.
01
Regular · Adaptive · Ongoing

3-Weekly Clinician Check-ins

Your dedicated GLP-1 specialist reviews your progress every 3 weeks — adjusting your dose, managing side effects, and evolving your plan as you respond. Not a one-off consultation.
02
Food · Movement · Mindset

Lifestyle & Habit Guidance

Food, movement, sleep and mindset coaching alongside your medication — with specific guidance on managing blood sugar through lifestyle, not just medication.
03
  • All treatments are subject to individual clinical assessment by a UK-registered clinician. Your clinician determines clinical suitability before any commitment is made. WeightFall is a managed weight management programme — not a substitute for your existing medical care. Always maintain your GP-prescribed treatments unless advised by a clinician.
Check My Eligibility
GLP-1 specialist clinicians · Reviewed within 1 working day
Member Stories

Real people, Real clinical results

Condition-specific health metrics — not just numbers on a scale.
“My GP told me I was on the cusp of Type 2. Six months into my WeightFall programme my fasting glucose is back in normal range.”
-14kg
Weight Loss
-1.2%
Fasting glucose
Weightfall clinical team
Sarah Jenkins
Member since 2023
“I had no idea insulin resistance was why I couldn’t lose weight. Once my clinician explained the biology and the GLP-1 medication started working, things finally shifted.”
-9kg
Weight Loss
Stable
HbA1c improved
Weightfall clinical team 2
David Miller
Member since 2024
“The intervention felt early enough to make a real difference. My clinician was proactive and knowledgeable. I feel like I actually reversed the trajectory.”
-8kg
Weight Loss
-Stable
HbA1c normalised 
Weightfall clinical team 2
David Miller
Member since 2024
Check My Eligibility
Takes 5 minutes · No commitment · Reviewed within 1 working day
The WeightFall Programme

Everything included — from £85/month

Every WeightFall programme includes the same level of clinical oversight, support and monitoring — regardless of which treatment your clinician recommends.

Clinical assessment & review

Your case reviewed by a GLP-1 specialist clinician before treatment begins. Condition-specific. Thorough. Personal.

Check-in every 3 weeks

Regular clinician review of your progress, dose and side effects. You’re never left to figure it out between appointments.

Dose adjustment support

Your plan adapts as you respond to treatment — no fixed templates. Dose escalation managed by your specialist throughout.

Lifestyle & habit guidance

Food, movement, sleep and mindset coaching alongside your treatment. Sustainable change, not just medication.

Fully online — no GP referral

Everything managed from home. A UK-registered clinician reviews your case and responds within 1 working day. Completely private.

Secure & confidential

Your health data handled with full clinical confidentiality. GDPR compliant. Secure encrypted platform.
Individual results vary. Data based on published clinical trial evidence. Your clinician will set realistic expectations for your specific case at assessment.

Your weight management journey

Week 1–4
Programme begins
Clinician reviews your case, dosing starts. First check-in at week 3. Most patients notice reduced appetite early on.
Month 1–3
Early progress
Appetite changes become more consistent. Dose adjusted as needed.
Month 3–6
Meaningful change

Progressive dose increases.
Body weight reduction. Lifestyle coaching
integrated alongside medication.

Month 6–12
Sustained results
Clinical trial shows body weight reduction. Clinician guides maintenance or tapering.
Programmes from
£85/month
Price varies by treatment type and dose. Your clinician confirms before any commitment.
  • Clinical assessment & review by GLP-1 specialist
  • Check-in every 3 weeks throughout your programme
  • Dose adjustment — no fixed templates
  • Lifestyle & habit guidance included
  • Fully online — no GP referral needed
  • Secure & confidential — your data protected
Check My Eligibility
If you’re not clinically eligible, you won’t be charged for treatment.
  • All treatments are subject to clinical assessment. WeightFall does not guarantee any specific health or weight outcome. Results depend on individual health status and adherence. Individual results vary significantly. Your clinician will set realistic expectations specific to your case.

Evidence-based. Peer-reviewed. Regulated.

Every element of the WeightFall programme is grounded in clinical evidence. Our approach is informed by the highest-quality published studies — and updated as new evidence emerges.
01
Finnish Diabetes Prevention Study — NEJM 2001
Intensive lifestyle intervention reduced risk of Type 2 diabetes by 58% in high-risk individuals. Weight loss of 5% was the key threshold.
Read full study
02
US Diabetes Prevention Program — NEJM 2002
Lifestyle intervention (7% weight loss) reduced T2D incidence by 58% vs placebo over 2.8 years — outperforming metformin alone.
Read full study
03
Tabák AG et al. — The Lancet 2012
Prediabetes is a high-risk, reversible state. Weight management via GLP-1 mechanisms is identified as the primary evidence-based intervention.
Read full study

Regulatory statement (CAP Code 12.1): WeightFall is a clinician-led weight management service. All treatments are prescription-only and subject to clinical assessment by UK- registered clinicians. WeightFall does not diagnose, treat, or cure any medical condition. Clinicians are registered with the General Medical Council (GMC). This service is not a substitute for NHS care.

Your questions, answered

Condition-specific answers — straight from our clinical team.

Find Out If You're Eligible

We’ll ask you a few quick questions to help determine your eligibility for treatment. Your responses will remain private and confidential.
Check My Eligibility
Frame 1321315189 1
Is this a medical treatment for insulin resistance treatment?

Weightfall provides clinician-led weight loss treatment. We do not claim to treat or reverse prediabetes. Results may vary with each individual

No — individual results vary significantly. No specific health or weight outcome is guaranteed.
GLP-1 receptor agonists work directly on insulin sensitivity — this is part of their mechanism. Your clinician will assess whether medication is appropriate for your specific case.
No. If your blood sugar has been flagged as elevated, or you have risk factors for insulin resistance, your clinician assessment will evaluate your eligibility.
The NHS DPP is excellent but typically has 12–24 month waits. WeightFall offers clinician-reviewed medicated weight management within 1 working day, with 3-weekly specialist check-ins.
Every 3 weeks your GLP-1 specialist clinician reviews your progress, weight, side effects, and plan. They adjust your dose or approach as needed. Everything online — no appointments.
Not without consent. We recommend informing your GP and can share progress summaries with your permission.
If a clinician determines treatment isn’t appropriate for you, your payment for that order is refunded. You won’t be charged for treatment you can’t receive.

First treatment dose, clinical assessment review, clinician sign-off, and first 3-weekly check-in. Prices vary by treatment type and dose — full breakdown before any commitment.

No. You’re not locked in. Treatment is reviewed continuously and your clinician will guide you on tapering if you choose to stop.
Comorbidities including high blood pressure, high cholesterol, and PCOS are commonly managed alongside prediabetes. Your full health profile is assessed before treatment begins.
GLP-1 medication typically begins showing appetite effects within 2–4 weeks. Meaningful metabolic marker changes typically appear at the 3–6 month stage. Individual results vary — your clinician sets realistic expectations at assessment.